Eye Infections Therapeutics Market by Type and Geography - Global Forecast and Analysis 2019-2023

The global eye infections therapeutics market has the potential to grow by USD 342.39 million during 2019-2023. The growth momentum will accelerate throughout the forecast period, and the market will grow at a CAGR of nearly 3%.

Rising geriatric population and the increasing adoption of generics are some of the major factors driving market growth. The US, Germany, and China are currently the major markets for eye infections therapeutics.

Eye Infections Therapeutics Market Report - Key Insights

Scope of the Market

The report provides a detailed analysis of the market by type and geography. Also, the report analyzes the market’s competitive landscape and offers information on several market vendors.

Browse TOC and LoE with selected illustrations and example pages from eye infections therapeutics market report

Request a FREE sample now!

Market Segmentation

Eye Infections Therapeutics Market by Type

• Conjunctivitis
• Keratitis
• Blepharitis
• Other eye infections

Eye Infections Therapeutics Market by Region

• Asia
• Europe
• North America
• ROW

Market Competitive Analysis

The eye infections therapeutics market is fragmented, and the degree of fragmentation will slightly increase during the forecast period. To increase the adoption of drugs for eye infections, vendors in the market are focusing on creating awareness campaigns. Akorn Inc., Allergan Plc, and Bausch Health Companies Inc. are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the side effects associated with antibiotics will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The report provides information on the production, sustainability, and prospects of several companies, including:

• Akorn Inc.
• Allergan Plc
• Bausch Health Companies, Inc.
• Bayer AG
• Daiichi Sankyo Co. Ltd.
• GlaxoSmithKline Plc
• Novartis AG
• Pfizer Inc.
• Sanofi
• Santen Pharmaceutical Co. Ltd.

Eye Infections Therapeutics Market: Key Drivers and Trends

The geriatric population is more vulnerable to eye infections as old age people are more prone to ophthalmic problems. Old age patients with eye infections require special medical attention as the condition could become severe if left unattended. Conditions such as tearing or excess tear production in older people increase microbial infections. This has increased in number of patient visits at ophthalmologists. The coming years will witness an increase in the number of patients with ocular problems. This will subsequently fuel the growth of the global eye infections therapeutics market size during the forecast period.

• Eye infections therapeutics market trends, such as the rising adoption of generic drugs, will also influence market growth.
• The regulatory approval process for generic drugs is equally similar to that for branded drugs
• Generic drugs have similar active ingredients, similar benefits, and risks when compared to branded drugs.
• Generic drugs do not undergo clinical trials on animals and humans. This has significantly reduced the cost of generic drugs.
• Many patients and doctors are increasing their preference for generic drugs.
• The rising prevalence of eye infections is expected to increase the demand for generic drugs.
• During 2019-2023, the market will register a CAGR of nearly 3%.

Eye Infections Therapeutics Market: Segmentation by Region

For more insights on the market share of various regions Request for a FREE sample now!

Rising incidences of the misuse of contact lens have increased the prevalence of eye infections in North America. This coupled with the rising awareness, and the presence of technologically advanced healthcare infrastructure are fostering eye infections therapeutics market growth in the region.

During the forecast period, more than 42% of the market growth will originate from North America. However, market growth in the region will be slower than the growth of the market in Asia.

Eye Infections Therapeutics Market: Segmentation by Type

Request for a FREE sample and Get more information on the market contribution from various infection types

The rising prevalence of conjunctivitis and the growing awareness about eye infections are driving the adoption of eye infections therapeutics. The availability of treatment for bacterial conjunctivitis in the form of eye drops, pills, and ointments have further increased boosted the growth of the market in the conjunctivitis segment.

As a result, the eye infections therapeutics market size will steadily grow in the conjunctivitis segment during the forecast period. However, market growth in the conjunctivitis segment will be slower than the growth of the market in keratitis segment.

Eye Infections Therapeutics Market: Key Highlights of the Report

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the eye infections treatment market size during the next five years
• Precise estimation of the global eye infections therapeutics market size and its contribution to the parent market
• Accurate eye infections therapeutics market forecast on upcoming trends and changes in consumer behavior
• The growth of the eye infections therapeutics industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of eye infections treatment market companies

We can help! Our analysts can customize this report to meet your requirements. Get in touch